AI-GF-GNW on Prolonged Grief Reactions

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age10-19
SponsorPeking University

About this trial

Prolonged Grief Disorder (PGD) is a severe, disabling condition characterized by intense yearning and difficulty accepting the reality of loss, which significantly impairs the academic and psychosocial functioning of bereaved adolescents. While Grief-Focused Cognitive Behavioral Therapy (GF-CBT) is effective, its high cost and resource-intensive nature limit its accessibility for adolescents in mainland China. Grief-Focused Guided Narrative Writing (GF-GNW) offers a scalable, low-cost alternative that facilitates memory integration.

Furthermore, integrating Artificial Intelligence (AI) to provide personalized, structured feedback has the potential to simulate therapist functions and enhance intervention efficacy. However, the specific efficacy of AI-assisted feedback in this context remains empirically unvalidated.

This parallel randomized controlled trial aims to examine the effectiveness of AI-assisted GF-GNW (AI-GF-GNW) in treating Chinese adolescents (aged 10-19) with subclinical PGD, compared to a no-feedback NF-GF-GNW group and a free writing group. Primary outcomes include PGD symptom severity, while secondary outcomes assess depression, anxiety, and daily functioning. We hypothesize that both active intervention arms will significantly alleviate PGD and related symptoms compared to the free writing group, and that the AI-GF-GNW group will demonstrate a significantly greater reduction in symptoms and functional impairment than the NF-GF-GNW group.

Eligibility criteria

Qualifiers

Junior and senior high school students currently studying in Chinese Mainland, aged 10-19;

Between 6 and 60 months prior to the experimental period, experienced the death of a significant family member or close friend or close friend;

The total symptom score of PG-13-R is between 20-29 points;

Ability to write and understand written guidelines, to use the mobile phone to interact with AI;

Disqualifiers

Diagnosed or previously diagnosed with mental illness

The bereavement time does not meet the time window

PG-13-R score is not within the range

At present, there is suicidal ideation or recent severe self harm behavior (Reynolds' Suicidal Ideation Questionnaire, SIQ-JR-4>0), and a crisis intervention hotline is provided when necessary.

Trial design

Treatments tested in this trial

  • AI-Assisted Grief-Focused Guided Narrative Writing
  • No-Feedback Guided Narrative Writing
  • Free Writing

Treatment groups

126 Participants
are divided into 3 treatment groups

Sponsors and collaborators